Skip to main content
U.S. flag

An official website of the United States government

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Search help
1,118 results
  1. NLM Digital Collections - Japanese medical material (Number 247, July 22, 1946) 
    resource.nlm.nih.gov/101619083X57
    ... IMPORTANCE: Not preciously reported, A preparation of coniferous enzymes dissolved in oil of oak seed and intended for cancer therapy. No identical preparation is listed in available standard American references< DESCRIPTION: Six ampuls, each containing 1 cc, of ...
  2. NLM Digital Collections - Slowly progressive, low-prevalence rare diseases with substrate deposition that result from ... 
    Publication: Silver Spring, MD : Center for Drug Evaluation and Research, March 2020
    resource.nlm.nih.gov/101772671
    ... of Substrate Reduction ................................................................................ 7 ... Therapies Guidance for Industry 1 This guidance represents the ...
  3. NLM Digital Collections - Pathology and physiology of burns : 1942-1951 : an annotated bibliography 
    Publication: Washington, D.C. : Armed Forces Medical Library, [1952]
    resource.nlm.nih.gov/60020290R
    ... of plasma may have a place In the therapeutic plan of protein restoration. The status of the usefulness of the enzyme In this later period is not established." 20 references. 109. Stolfi, G. Studl sperlmentali sulle ustioni. Ann. ...
  4. NLM Digital Collections - Smoking and Health: A Report of the Surgeon General 
    Publication: United States. Office on Smoking and Health, 1979
    resource.nlm.nih.gov/101584932X630
    ... body clearance and anticoagulant effect. Clinical Pharmacology and Therapeutics 19(5): 552-558, 1976. (92) YAMAMOTO, I, NAGAI, K., KIMURA, H., IWATSUBO, K. Nicotine and some carcinogens in special reference to the hepatic drug-metabolizing enzymes. Japanese Journal of Pharmacology 16: 183-190, 1966. ( ...
  5. NLM Digital Collections - Smoking and Health: A Report of the Surgeon General (pages 12-43 through 12-67) 
    Publication: United States. Office on Smoking and Health, 1979
    resource.nlm.nih.gov/101584932X654
    ... body clearance and anticoagulant effect. Clinical Pharmacology and Therapeutics 19(5): 552-558, 1976. (92) YAMAMOTO, I, NAGAI, K., KIMURA, H., IWATSUBO, K. Nicotine and some carcinogens in special reference to the hepatic drug-metabolizing enzymes. Japanese Journal of Pharmacology 16: 183-190, 1966. ( ...
  6. NLM Digital Collections - How prescription drug use affects health care utilization and spending by older Americans : a ... 
    Publication: Washington, D.C. : AARP Public Policy Institute, c2008
    resource.nlm.nih.gov/101476705
    ... The expenditures, MD probability of stopping ... 65+, British hypertensive) et savings. Quasi- ...
  7. NLM Digital Collections - C. Everett Koop's curriculum vitae 
    Publication: Produced: February 1986
    resource.nlm.nih.gov/101584930X38
    ... E., Johnson, D.G.: Neuroblastoma: An Assessment of Therapy in Reference to ... Deficiency Associated with Asphyxiating Thoracic Dystrophy. Arch. Dis. ...
  8. NLM Digital Collections - Briefing Book, 1989-1990 
    https://resource.nlm.nih.gov/101083016X51
    ... several cellular systems and an analog 99-residue enzyme has been chemical- ly ... for anti-HIV therapies. A candidate drug for this approach is ampligen, ...
  9. NLM Digital Collections - COVID-19 : potency assay considerations for monoclonal antibodies and other therapeutic ... 
    Publication: [Silver Spring, MD] : Center for Drug Evaluation and Research, January 2021
    resource.nlm.nih.gov/9918250311706676
    ... monitor the binding between the mAb or other therapeutic protein and its target. ... in-house reference material and activity should be expressed as a ...
  10. NLM Digital Collections - Human gene therapy for rare diseases 
    Publication: Silver Spring, MD : Center for Biologics Evaluation and Research, January 2020
    resource.nlm.nih.gov/101767660
    ... drugs/cder-biomarker-qualification-program/biomarker-guidances-and-reference-materials. ... start with a potentially therapeutic dose. However, dose exploration may be needed to ...
first · previous · 1 · 2 · 3 · 4 · 5 · 6 · 7 · 8 · 9 · 10 · next · last